Transforming growth factor beta1 (TGF-beta) is widely acknowledged as a potent inhibitor of human and mouse mammary epithelial proliferation. We have localized its activity in the mouse mammary gland and characterized the proliferative phenotype of the Tgfbeta1 heterozygote mouse: both are regulated by the ovarian hormones estrogen and progesterone. It is well known that estrogen signaling through estrogen receptor ? (ER) plays a central role in mammary epithelial cell proliferation. Several recent studies have shown that the majority of estrogen receptor-positive (ER+) cells do not proliferate, but are required to regulate proliferation in ER-negative (ER-) cells via paracrine mechanisms. The small subpopulation (approximately 1% in human and mouse breast) of ER+ cells that maintain proliferative potential has been postulated to be early progenitor cells that could be the origin of ER+ breast cancer. We found that nearly all of the ER+ cells in mouse mammary gland at estrus co-localize with intense TGF-beta activity, consistent with their non-proliferative status. However, proliferation of ER+ cells is increased more than 2-fold in Tgfbeta1 heterozygote mammary gland, which furthermore resulted in a 30% increase in the total number of ER+ cells compared to wildtype mammary epithelium. Based on these observations we hypothesize that TGF-beta actively restrains proliferation of mammary epithelial cells and, in particular, regulates the subpopulation of ER+ cells that are speculated to represent lineage-restricted progenitor. To the extent that stem cells/progenitors are targets for carcinogenesis, we further hypothesize that disruption of TGF-beta action is involved in the genesis of ER+ breast cancer. Our overall goal, therefore, is to define the functional relationship between TGF-beta1 and the population of ER+ replicative cells as a function of age.
Three aims are proposed: 1: To determine the frequency of ER+ cells as a function of TGF-beta1 level, localization and activity. 2: To analyze TGF-beta effects on the replicative potential of presumptive mammary stem cells. 3: To determine whether TGF-beta regulation of the ER+ subpopulation contributes to progression and/or features of preneoplastic lesions.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project (R01)
Project #
Application #
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Bellino, Francis
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Lawrence Berkeley National Laboratory
Organized Research Units
United States
Zip Code
Simian, Marina; Bissell, Mina J; Barcellos-Hoff, Mary Helen et al. (2009) Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice. Breast Cancer Res 11:R72
Muraoka-Cook, R S; Shin, I; Yi, J Y et al. (2006) Activated type I TGFbeta receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression. Oncogene 25:3408-23
Ewan, Kenneth B R; Oketch-Rabah, Hellen A; Ravani, Shraddha A et al. (2005) Proliferation of estrogen receptor-alpha-positive mammary epithelial cells is restrained by transforming growth factor-beta1 in adult mice. Am J Pathol 167:409-17
Muraoka-Cook, Rebecca S; Kurokawa, Hirokazu; Koh, Yasuhiro et al. (2004) Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res 64:9002-11